BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9133754)

  • 1. Therapeutic trial participants: where do we find them and what does it cost?
    Bielski RJ; Lydiard RB
    Psychopharmacol Bull; 1997; 33(1):75-8. PubMed ID: 9133754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and enrolling subjects in a randomized clinical trial involving implant dentures.
    Walton JN; MacEntee MI
    Int J Prosthodont; 2008; 21(3):210-4. PubMed ID: 18548957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost-Time Index: a new method for measuring the efficiencies of recruitment-resources in clinical trials.
    Ota KS; Friedman L; Ashford JW; Hernandez B; Penner AL; Stepp AM; Raam R; Yesavage JA
    Contemp Clin Trials; 2006 Dec; 27(6):494-7. PubMed ID: 16820328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors related to volunteer comprehension of informed consent for a clinical trial.
    Kaewpoonsri N; Okanurak K; Kitayaporn D; Kaewkungwal J; Vijaykadga S; Thamaree S
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):996-1004. PubMed ID: 17333746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
    Bennett CL; Oddone E; Matchar D
    Clin Perform Qual Health Care; 1995; 3(3):156-64. PubMed ID: 10151167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis.
    Pope JE; Prashker M; Anderson J
    J Rheumatol; 2004 Jan; 31(1):140-9. PubMed ID: 14705233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International aspects of problems associated with the use of psychoactive drugs.
    Chruściel TL
    Bull Narc; 1976; 28(2):35-48. PubMed ID: 1048933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative recruitment experience in two large single-center randomized, controlled clinical trials.
    Galbreath AD; Smith B; Wood P; Forkner E; Peters JI
    Contemp Clin Trials; 2008 May; 29(3):335-42. PubMed ID: 18032118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS; Sorensen SV; Liu LZ; Itani KM
    Ann Pharmacother; 2006 Jun; 40(6):1017-23. PubMed ID: 16720705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing onset in psychopharmacological clinical trials.
    Laska EM; Siegel C
    Psychopharmacol Bull; 1995; 31(1):29-35. PubMed ID: 7675985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug trials on healthy volunteers in Yugoslavia.
    Vrhovac R; Francetić I; Rotim K
    Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):375-9. PubMed ID: 2228323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting phobic research subjects: effectiveness and cost.
    Kaakko T; Murtomaa H; Milgrom P; Getz T; Ramsay DS; Coldwell SE
    Anesth Prog; 2001; 48(1):3-8. PubMed ID: 11495403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic volunteers in multicenter drug trials.
    Covi L; Lipman RS; McNair DM; Czerlinsky T
    Prog Neuropsychopharmacol; 1979; 3(5-6):521-33. PubMed ID: 401003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.